In a patient with prior bilateral lower extremity stents for peripheral vascular disease who now has recurrent leg swelling, should repeat arterial Doppler studies still show moderate to severe arterial compromise, or is additional stenting required?

Recurrent Leg Swelling After Bilateral Lower Extremity Stents: Arterial Doppler Findings and Need for Additional Intervention

In a patient with recurrent leg swelling after bilateral lower extremity stent placement for PAD, arterial Doppler ultrasound should be performed immediately to assess for in-stent restenosis or occlusion, as recurrent symptoms are the most important indicator of stent failure and warrant prompt evaluation regardless of whether moderate-to-severe arterial compromise is detected. 1

Critical Clinical Context: Swelling vs. Arterial Disease

Important caveat: Bilateral leg swelling is not a typical presentation of arterial insufficiency or PAD. Arterial disease typically presents with claudication, rest pain, non-healing ulcers, or gangrene—not bilateral edema 1. Bilateral lower extremity swelling more commonly suggests:

• Venous disease (chronic venous insufficiency, deep vein thrombosis)
• Cardiac dysfunction (heart failure)
• Renal disease
• Lymphatic obstruction
• Medication side effects (calcium channel blockers)

You must first determine if this is truly an arterial problem or a venous/systemic issue. 2

Diagnostic Approach: Arterial Assessment

Initial Evaluation (Perform Immediately)

1. Clinical Assessment:

• Check for recurrent claudication symptoms (leg pain with walking that resolves with rest)
• Assess for rest pain (pain at night or when leg elevated)
• Examine for non-healing ulcers or gangrene
• Palpate pedal pulses (dorsalis pedis and posterior tibial)
• Measure ankle-brachial index (ABI) at rest 1, 3

2. Arterial Duplex Ultrasound (DUS):

• This is your first-line imaging study 1, 3
• Peak systolic velocity (PSV) ratios ≥2.5 at the stent site correlate with hemodynamically significant restenosis and symptom recurrence 1
• DUS can detect in-stent restenosis, adjacent segment disease, or complete occlusion 1

What the Doppler Will Show

If stents are failing, you will typically see:

• Elevated PSV ratios (≥2.5) indicating ≥50% stenosis 1
• Decreased or absent flow through previously stented segments
• Abnormal spectral waveforms (dampened, monophasic patterns)
• Drop in ABI compared to post-procedure baseline 1, 3

However: The absence of severe arterial compromise on Doppler does not rule out the need for intervention if symptoms persist 1. Conversely, finding arterial disease doesn't explain bilateral swelling.

Surveillance and Follow-Up After Stenting

Standard Post-Stent Surveillance Protocol 3

For patients who underwent endovascular stenting without new symptoms:

• DUS surveillance at 1-3 months post-procedure
• Repeat at 6 months
• Repeat at 12 months
• Then annually thereafter

For patients WITH new lower extremity signs or symptoms (like your patient):

• Immediate ABI and arterial duplex ultrasound is recommended 3
• Do not wait for scheduled surveillance intervals

When Additional Stenting Is Needed

Indications for repeat revascularization: 1, 3, 4

1. Recurrent claudication with documented restenosis (PSV ratio ≥2.5)
2. Critical limb-threatening ischemia (CLTI): rest pain, non-healing ulcers, gangrene
3. Significant drop in ABI (>0.15 decrease from post-procedure baseline)
4. Stent occlusion on imaging with symptoms

NOT indicated for:

• Asymptomatic restenosis detected on surveillance imaging 1
• Bilateral leg swelling alone without arterial symptoms

Alternative Diagnosis: Consider Venous Disease

Given bilateral swelling, you must evaluate for venous pathology: 2, 5

Venous Duplex Ultrasound Indications

• Assess for deep vein thrombosis (DVT) 5
• Evaluate for chronic venous insufficiency with reflux 2
• Check for iliac vein compression or stenosis (May-Thurner syndrome) 2

Key point: 16% of patients with venous leg ulcers have concomitant arterial disease 2, so both arterial and venous systems may need evaluation.

Clinical Decision Algorithm

Step 1: Perform ABI and arterial duplex ultrasound

• If ABI decreased >0.15 from baseline OR PSV ratio ≥2.5 → Proceed to Step 2
• If ABI normal and no arterial abnormalities → Proceed to Step 3

Step 2: Assess for arterial symptoms (claudication, rest pain, tissue loss)

• If present → Consider repeat revascularization (angiography ± intervention)
• If absent → Medical management, close surveillance

Step 3: Evaluate for non-arterial causes of bilateral swelling

• Venous duplex ultrasound for DVT/chronic venous insufficiency
• Echocardiogram if cardiac dysfunction suspected
• Renal function tests
• Review medications

Medical Management Regardless of Findings 6, 3, 4

All patients with prior PAD stenting require lifelong guideline-directed medical therapy (GDMT):

• Antiplatelet therapy: Aspirin 75-100 mg daily 6, 4
• Consider dual antiplatelet therapy (DAPT): Aspirin + clopidogrel for high-risk patients or immediately post-revascularization 6, 3
• Consider rivaroxaban 2.5 mg twice daily + aspirin 100 mg daily for patients at high ischemic risk without high bleeding risk 4
• High-intensity statin: Target LDL <55 mg/dL 6, 7, 4
• Blood pressure control
• Diabetes management if applicable
• Smoking cessation (mandatory) 6, 4

Bottom Line

Arterial Doppler can show moderate-to-severe compromise if in-stent restenosis or occlusion has occurred, but bilateral leg swelling is not a typical arterial presentation. You need to:

1. Perform arterial duplex ultrasound immediately to assess stent patency 3
2. Simultaneously evaluate for venous disease as the more likely cause of bilateral swelling 2
3. Additional stenting is only warranted if there is documented arterial restenosis/occlusion PLUS arterial symptoms (claudication, rest pain, tissue loss) 1, 3
4. Asymptomatic restenosis alone does not require intervention 1

The presence of recurrent swelling alone, without classic arterial symptoms, should prompt investigation of alternative etiologies before pursuing repeat arterial intervention.